COVID-19

Virus infection creates immunity for at least 6 months – study

Agence France-Presse

This is AI generated summarization, which may have errors. For context, always refer to the full article.

FIGHTING THE VIRUS. In this file photo taken on July 8, 2020 a woman walks in front of a mural depicting a man in protective suit spraying disinfectant on coronavirus with Brazilian President Jair Bolsonaro's face, at the Tijuca neighborhood in Rio de Janeiro, Brazil.

File photo by Mauro Pimentel/AFP

'We can be confident that, at least in the short term, most people who get COVID-19 won't get it again,' says one of the authors of the study

Individuals infected with coronavirus are unlikely to catch the illness again for at least 6 months, researchers at the University of Oxford said Friday, November 20.

The finding comes as part of a large-scale study into COVID-19 reinfection after observations from healthcare professionals that the phenomenon was relatively rare.

Oxford University Professor David Eyre, one of the authors of the study, said the findings were “really good news”.

“We can be confident that, at least in the short term, most people who get COVID-19 won’t get it again,” he said.

The authors highlighted they had not yet gathered enough data to make a judgement on reinfection after 6 months.

However, the ongoing study has an end goal of verifying how long protection from reinfection lasts in total.

The director of infection prevention and control at study partners Oxford University Hospitals (OUH), Katie Jeffery, called the finding “exciting”.

It indicated “that infection with the virus provides at least short-term protection from reinfection,” she added.

US biotech firm Moderna announced this week its vaccine candidate was nearly 95% effective in a trial – a week after similar results were announced by pharma giant Pfizer and its German partner BioNTech.

The Oxford study into reinfection drew on data from regular coronavirus testing of 12,180 health care workers at OUH over a period of 30 weeks.

It found that none of the 1,246 staff with coronavirus antibodies developed a symptomatic infection.

Three members of staff with antibodies did test positive for the virus that causes COVID-19 but were all well and did not develop symptoms. – Rappler.com

Add a comment

Sort by

There are no comments yet. Add your comment to start the conversation.

Summarize this article with AI

How does this make you feel?

Loading
Download the Rappler App!